Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response Life Science Investing
Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research Life Science Investing
Medtronic announces closing of public offering of Euro3.0 billion of senior notes Life Science Investing
